No shortage on file

PROHANCE

BRACCO IMAGING CANADA

Quick answers

Is there a shortage of PROHANCE in Canada?

No. There is no current shortage of PROHANCE 279.3MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-12

DIN

02229056

Strength

279.3MG

Dosage Form

Solution

Route

Intravenous

Active Ingredient

GADOTERIDOL

See all GADOTERIDOL products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from BRACCO IMAGING CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV

52% · DIN 02228556

DIN 02228564

ISOVUE 200 INJECTION

41% · DIN 02229013

ISOVUE 300 INJECTION

61% · DIN 02229021

ISOVUE 370 INJECTION

76% · DIN 02229048

ISOVUE MULTIPACK-300

61% · DIN 02242122

ISOVUE MULTIPACK-370

76% · DIN 02242121

5MCG · DIN 02228602

529MG · DIN 02248302

SINOGRAFIN - LIQ IU

DIN 02228599

8MCL · DIN 02287684

485.1MG · DIN 02567334